MedPath

Strides Pharma hits all time high after USFDA approval for this drug | News on Markets

Strides Pharma share price hit an all-time high after its Singapore subsidiary received USFDA approval for generic Theophylline extended-release tablets, to be manufactured in Bangalore.


Reference News

Strides Pharma hits all time high after USFDA approval for this drug | News on Markets

Strides Pharma share price hit an all-time high after its Singapore subsidiary received USFDA approval for generic Theophylline extended-release tablets, to be manufactured in Bangalore.

Strides Pharma Share Price Jumps after Theophylline Tablet Gets US FDA Approval

Strides Pharma shares surged to an all-time high of ₹1,395 after its subsidiary received USFDA approval for a generic Theophylline extended-release tablet, enhancing its U.S. market presence.

© Copyright 2025. All Rights Reserved by MedPath